Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.50

  • SJR 0.263

  • Impact Factor 0.5 (2023)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus

Molecular and Immunopathological Investigations of Marek’s Disease in HVT Vaccinated Chicken Flocks

Shailja Pandey1, Deepika Lather1,*, Aman Kumar2, Vikas Nehra1, Babu Lal Jangir 1, Gulshan Narang1
1Department of Veterinary Pathology, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar-125 004, Haryana, India.
2Department of Animal Biotechnology, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar-125 004, Haryana, India.
Background: The present investigation was carried out on poultry carcasses brought to the Department of Veterinary Pathology, LUVAS, Hisar from Herpesvirus of turkeys (HVT) vaccinated chicken flocks and suspected for viral neoplastic conditions on the basis of necropsy. Conventional and molecular techniques for the confirmation of the Marek’s disease (MD) were studied. For differential diagnosis from other oncogenic viral infections immunohistochemistry as an important tool was investigated. 

Methods: The conventional diagnosis of MD) was done on basis of clinical signs, gross lesions and histopathology of proliferate lesions; as lymphomatous lesions consist of pleomorphic lymphocytes. For confirmatory diagnosis molecular techniques were employed to detect MD virus specific Meq gene by Taqman probe real time PCR and nested PCR. For differential diagnosis of mixed oncogenic viral infections, immunohistochemistry (IHC) using B and T cell differentiation markers (CD79 alpha and CD3) was employed.

Result: Specific Meq gene by Taqman probe real time PCR was positive in 92.5% suspected cases; while nested PCR technique gave positivity in 55% cases. The immunohistochemical reactivity for CD3 gave positive reactivity in the cytoplasm and cell membrane and negative reaction for CD79 alpha in MD positive cases, while in cases with mixed infections of MDV and other viral neoplastic conditions, cells showed positive reactivity to both CD3 and CD79 alpha in neoplastic proliferates. 
Marek’s disease virus serotype 1 (MDV1) is an oncogenic DNA virus which belongs to the family Herpesviridae subfamily Alphaherpesvirinae and genus Mardivirus causing the Marek’s disease (MD) of poultry. Major broader clinical signs in MD are immunosuppression, polyneuritis and lymphoproliferative nodules formation in the visceral and cutaneous tissues (Witter and Schat, 2003). The traditional diagnosis of MD is based on clinical signs and gross pathology. Histopathological examination of proliferate lesions is also very important in diagnosing MD; as lymphomatous lesions consist of pleomorphic lymphocytes. Even with the intensive vaccination practice, outbreaks of MDV associated lymphocytic tumors and paralysis was reported from India (Kamaldeep, 2007) and other countries resulting in great economic losses. Additionally, the increasing virulence and the immunosuppressive effect of MDV makes it a threat to broiler industry as it has been reported to increase their susceptibility to Escherichia coli and infectious bronchitis (IB) infection (Islam et al., 2002). 
       
Prompt and differential disease diagnosis therefore plays a key role to minimise the losses by enabling early adaptation of proper control and preventive measures. The principal methods to confirm the avian oncogenic diseases are isolation of the virus, demonstration of viral DNA or antigens in tissues and detection of antibody (Schat and Nair, 2008). PCR appears to be a method of choice for the diagnosis of avian oncogenic viruses and IHC can be used in differential diagnosis of these neoplastic conditions (Gopal et al., 2012). Therefore; for optimizing production, it is mandatory to use the correct pathological, microbiological and other diagnostic techniques, which may be helpful to check the disease occurrence and minimize the losses in production.
               
In the present study, we report the diagnostic investigation of MD in HVT vaccinated organized poultry farms of Haryana using immunopathohistochemical and molecular techniques.
The present investigation was carried out on 40 cases received from HVT vaccinated organized poultry farms suspected for viral neoplastic conditions on the basis of gross and histopathological lesions which were brought to the Department of Veterinary Pathology, LUVAS, Hisar during the period of 6 months (from August 2018 to January 2019).
 
History and collection of samples
 
The detailed identification of all the carcasses was recorded as per requisition form. Representative tissue samples from abnormal nodular growths were collected during necropsy in 10% neutral buffered formalin for histopathological and immunohistochemical studies and in separate sterile vials without preservative which were stored at -20°C for molecular studies.
 
Molecular studies
 
Molecular diagnosis and characterization studies were carried out to detect MD virus specific Meq gene by Taqman probe real time PCR and nested PCR in all the cases which revealed lymphomas on the basis of gross and histopathological examination.
 
TaqMan probe real time PCR for target Meq gene of Marek’s disease virus
 
Total genomic DNA was extracted from liver tumor tissue samples (400 mg) using commercially available genomic extraction DNA Mini Kit (DNeasy® Blood and Tissue Kit, Invitrogen) as per manufacturer’s tissue protocol. For the identification of MDV specific target gene (Meq), a Taqman probe real time PCR assay was performed using real time PCR Applied Biosystems (Step one plus) for data acquisition and analysis. The reaction for the meq gene was carried out in triplicate for each sample. Oligonucleotide primers and probes used in the PCR are described in Table 1. The results for TaqMan probe real time PCR were analyzed on the basis of their cycle threshold (CT) values.
 

Table 1: Oligonucleotide primers and probes used in TaqMan probe real time PCR for Meq gene.


 
Nested PCR for target Meq gene of Marek’s disease virus
 
All the samples screened by TaqMan probe real time PCR were also subjected for nested PCR for qualitative analysis. The first round of PCR was performed with the primer set M-S and M-AS to amplify a 1,062-bp Meq gene fragments (Lee et al., 2000). The sequences of MDV specific primers (Murata et al., 2007) used are shown in the Table 2. The second round of PCR was performed using primer set of MR-S and MR-AS to amplify a 583-bp Meq gene (Chang et al., 2002). The expected size of PCR product was estimated by comparison with that of standard DNA ladder.
 

Table 2: Sequences of MDV specific Meq primers used for nested PCR amplification.

   
 
Immunohistochemical studies
 
Immunohistochemical staining using primary antibodies for B and T cell differentiation markers i.e. CD79 alpha (anti-chicken Invitrogen; CAT No.MA5-13212) and CD3 (anti-chicken Invitrogen CAT No. MA5-28699) was done in formalin fixed tumor tissues as per standard protocol (Ramos-Vara et al., 2014). Antigen retrieval was performed by microwave irradiation with 0.01 M citric buffer, pH 6.0, for 10×2 minutes. Optimal concentration of each primary antibody was determined by standard protocol. Immunohistochemical staining was accessed as negative and positive groups. Brick red or brown red colour in membrane and cytoplasm of tumor cells was taken as positive.
Pathological studies revealed mortality due to neoplastic disease conditions in 12.15% cases; with 7.79% in layers, 2.12% in  broilers and 2.15% in dual purpose chicken breeds affecting mainly more than 18 weeks age group. Most of the affected chickens showed nonspecific clinical signs in the form of decreased feed intake, depression, emaciation and paleness. In contrary paralytic symptoms of the legs were not present and no lesions were detected in nerves, bursa of Fabricius, skin and eyes in our study.
       
Similar findings have also been observed by other researchers (Sani et al., 2017) who reported that the overall prevalence of avian neoplastic diseases was 7.58% with overall prevalence of MD as 6.25%. They further added that the average age of poultry affected was 20.17 (SD=±2.6) weeks for MD and 41.43 (SD=±15.4) weeks for AL with weight loss (55.98%), ruffled feathers (47.01%), diarrhea (39.79%) and leg paralysis (17.52%) as the most reported clinical signs. In agreement to our findings clinical signs of poor growth and production have also been reported by various researchers (Das et al., 2018). The existence of genetic resistance to MD among chickens and its influence on the outcome of MDV infection has been recognized since long (Payne and Venugopal, 2000). Similar to our observations, it has been observed that the mortality in broiler breeder was more in females than males (Eid et al., 2019); which indicate that the outcome of infection is influenced by sex, as females are usually more susceptible to the development of tumors (Payne and Venugopal, 2000). The occurrence of MD in vaccinated flocks has also been reported by earlier workers (Kamaldeep et al., 2007). Exposures to chicken anaemia virus infection, emergence of hyper virulent strains (Raja et al., 2009), with further increase in the virulence of field strain suggested to be the cause of vaccination failure and pathological picture change of this neoplastic disease (Gong et al., 2013).  Incidence of MD in commercial layer flocks despite vaccination  have also been related to vaccine failure consequent to prolonged exposure to high levels of trace elements, particularly lead and cadmium, leading to immunosuppression (Muniyellappa et al., 2015).
 
Grossly, nodular enlargements in liver, spleen, lungs, kidneys, proventriculus, intestine and ovaries were histopathologicaly confirmed by the proliferation and infiltration of pleomorphic lymphomatous cells, suggestive of MD. Microscopic lesions in MD are consisting of diffusely proliferating small-to- medium lymphocytes, lymphoblasts and activated and primitive reticulum cells. Published data suggests that all tumors with uniform lymphoblast population can be of MD or LL (Payne et al., 1976). In such cases, confirmatory diagnosis can be made based on immunocyto/histochemistry (Meq, IgM) and ruling-out virus infection (MDV/ALV) by PCR. Five cases in present study also revealed aggregates of uniform sized large lymphoid cells (lymphoblasts) suggestive of avian lymphoid leucosis (LL) indicating mixed infections of MD with ALV. Mixed infections need differentiation by a simultaneous immunoreactivity with both Meq and IgM for MD and LL specific immuno markers respectively. Histopathological evidence did not support the presence of reticuloendotheliosis (RE) type lesions in any case.
       
The results for TaqMan probe real time PCR indicated that 92.5% cases gave positive expression for MDV specific Meq gene; while 3 cases were undetermined. Amplification plot depicting CT (cycle threshold) values has been presented in Fig 1. The CT value ranged between14.69 to 35.9.  72.9% cases revealed CT value ³29 indicating strong positive, while 27.1% cases showed CT value between >29-37 indicating moderate positive result.
 

Fig 1: Amplification plot depicting CT values giving positive expression for MDV specific Meq gene in TaqMan probe real time PCR.


       
Results of nested PCR confirmed the presence of 583 bp product for MDV specific Meq  gene which is depicted in Fig 2. Out of total 40 cases, 22 cases showed positive expression of Meq gene of Marek’s disease virus. On comparison, the sensitivity of TaqMan probe real time PCR was 92.5% in detecting MDV specific target gene (Meq) while it was only 55% in case of nested PCR. The findings were more or less in agreement to those of other workers (Krol et al., 2007). Marek’s disease (MD) is caused by a cell-associated herpes virus and the genetic material of MDV is a linear, double stranded DNA molecule containing about 80 specific genes of MDV which encode peptides that have an essential significance for oncogenicity and pathogenicity. Main oncogenes are the products of gene Meq, pp38 and 132bp sequence. It was found that high loads of MDV DNA and expression of the MDV oncogene Meq were specific for MDV-induced lymphomas and valid criteria for MD diagnosis (Gimeno et al., 2005). Researchers also established that the Meq gene is necessary for the development of tumors and therefore is a key gene in the pathogenesis of MD (Lupiani et al., 2004). Molecular detection of MDV specific Meq gene DNA in tumors, especially neoplastic nodules consistent with gross and histopathological characteristics has been found to be reliable for MD diagnosis.
 

Fig 2: Resolution of nested PCR amplified product for Meq gene on 1.5% agarose gel.


       
Real-time polymerase chain reaction (PCR) methods based on different detection systems can determine the MDV genome loads based on either relative (Yunis et al., 2004) or absolute quantification (Baigent et al., 2005). The importance of real time PCR is to precisely distinguish and measure specific nucleic acid sequences in a sample, even if there is only a very small amount of DNA. The sensitivity of the real-time assay was found to be 2.5–10 times more than that of conventional PCR. Results of present study also indicate more sensitivity of real time PCR than nested PCR for Marek’s disease diagnosis which is in agreement to the findings of Dagher et al., (2004).
       
The result of immunohistochemical reactivity to B and T cell markers indicated that for CD3 antibody (T cell marker) was found to be positive in almost all MD positive cases with more than 90% cytoplasmic or membranous reactivity in neoplastic cells i.e. both small and large lymphocytes (Fig 3). In cases suspected of mixed infections, having both pleomorphic and uniform large lymphoblast cells, positive reactivity was observed in few pleomorphic neoplastic cells only (Fig 4). No immunoreactivity for CD79 alpha was observed in MD cases (Fig 5) but in few cases there was positive membranous and cytoplasmic immunoreactivity in few large lymphocytes cells particularly at perivascular locations. Mixed infection cases, revealed positive immunohistochemical reactivity to CD79 alpha marker in 20 to 50% neoplastic cells particularly in large uniform immature lymphoblast cells (Fig 6) indicating the presence of B cells in tumor tissue. Results therefore support the utility of immunohistochemical staining besides the histological appearance in differentiating MD from other neoplastic diseases.
 

Fig 3: Positive membranous and cytoplasmic immunoreactivity to CD3 in the neoplastic lymphoid cells in Marek’s disease affected liver tissue (IHC stain 200X).


 

Fig 4: Positive membranous and cytoplasmic immunoreactivity to CD3 in few pleomorphic neoplastic cells (MD+LL infection) (IHC stain 400X).


 

Fig 5: No immunoreactivity to CD79 alpha in neoplastic lymphoid cells in Marek’s disease affected liver tissue. Few necrotic hepatocytes showing positive reddish brown immunostaining in the cytoplasm (IHC stain 200X).


 

Fig 6: Positive membranous and cytoplasmic immunostaining to CD79 alpha in few neoplastic lymphoid cells (MD+LL mixed infection) (IHC stain 400X).


       
These findings were similar with the results of other researchers (Mete et al., 2016 and Eid et al., 2019). Negative immunoreactivity for CD79 alpha antibodies in pleomorphic lymphoid cells indicates that B cells did not comprise the neoplastic lymphoma lesions in MD. However, mixed infection cases indicate presence of both T and B cells in proliferating lymphomas. The findings were similar with the results of some workers (Pejovic et al., 2007 and Haridy et al., 2018) who revealed negative immunoreactivity of CD79 alpha in liver, kidney and spleen lymphomas in chickens and for CD20 (B-cell marker) and Pax5 (B-cell transcription factor) in white silkie fowl, respectively. According to our findings we also conclude that the CD3 cell population was dominant in MDV lesions. However, there were a modest percentage of CD79 alpha positive cells in the liver tumors, located perivascularly. In Marek’s disease B cells are infected with MDV during the cytolytic phase of infection. Therefore, B-cells do play an important role in MDV pathogenesis and their presence in MDV lymphomas was also previously reported (Payne et al., 1976). The results could be helpful in diagnosing mixed infections of MD and LL as well. Reports on multiple oncogenic virus infections have been described in literature and at times ALV and REV have been detected as contaminants in Marek’s disease vaccines (Zavala and Cheng, 2006).
It may be concluded from the present findings that immunohistochemistry and molecular technique employing TaqMan probe real time PCR using Meq oncogene in tumor tissues in addition to conventional methods such as necropsy and histopathology could be useful for confirmatory diagnosis of poultry viral neoplastic infections which is still posing to be a major problem in vaccinated chicken flocks.
Authors are highly thankful to the funding agency Rashtriya Krishi Vikas Yojna (RKVY) as the study was supported in part by the grant given to the Department of Veterinary Pathology, LUVAS, Hisar for RKVY-RAFTAAR project.
None.

  1. Baigent, S.J., Petherbridge, L.J., Howes, K., Smith, L.P., Currie, R.J., Nair, V.K. (2005). Absolute quantitation of Marek’s disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. Journal of Virological Methods. 123: 53-64.

  2. Chang, K.S., Lee, S.I., Ohashi, K. (2002). The detection of the MEQ gene in chicken infected with Marek’s disease virus serotype 1. Journal of Veterinary Medical Science. 64: 413-417.

  3. Das, S., Das, D., Panda, S., Sagarika, S.  Jena, B. (2018). Clinico- pathological studies of marek’s disease in chickens. International Journal of Livestock Research. 8(1): 207- 217. http://dx.doi.org/10.5455/ijlr.20170720115734. 

  4. Dagher, H., Donninger, H., Hatchinson, P., Ghildyal, R., Bardin, P. (2004). Rhinovirus detection: Comparison of real-time and conventional PCR. Journal of Virological Methods. 117: 113-121.

  5. Eid, A.E., Abd-Ellatieff, H.A., Ellakany, H.F., Abou-Rawash, A.R.A., Abd El-Hamid, H.S. (2019). Studies on tumor disease viruses in chickens in Egypt. Alexandria Journal of Veterinary  Sciences. 60(1): 184-195.

  6. Gimeno, I.M., Witter, R.L., Fadly, A.M., Silva, R.F. (2005). Novel criteria for the diagnosis of Marek’s disease virus-induced lymphomas. Avian Pathology. 34, 4, 332-340, DOI: 10.10 80/03079450500179715.

  7. Gong, Z., Zhang, L., Wang, J., Chen, L., Shan, H., Wang, Z., Ma, H. (2013). Isolation and analysis of a very virulent Marek’s disease virus strain in China. Virology Journal. 10: 155. doi.org/10.1186/1743-422X-10-155.

  8. Gopal, S., Manoharan, P., Kathaperumal, K.,  Chidambaram, B.,  Kurunchi, C.D. (2012). Differential detection of avian oncogenic viruses in poultry layer farms and turkeys by use of multiplex PCR. Journal of Clinical Microbiology. 50: 2668-2673.

  9. Haridy, M., Goryo, M., El-Neweshy, M. and Yanai, T. (2018). Visceral lymphomas due to co-infection of Marek’s disease virus- avian leukosis virus AE in Japanese silkie fowl. Japanese Journal of Veterinary Research. 67(1): 41-50.

  10. Islam, A.F.M.F., Wong, C.W., Walkden-Brown, S.W., Colditz, I.G., Arzey, K.E., Groves, P.J. (2002). Immunosuppressive effects of Marek’s disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge. Avian Pathology. 31(5): 449-461.

  11. Jones, D., Lee, L., Liu, J.L., Kung, H.J., Tillotson, J.K. (1992). Marek disease virus encodes a basic-leucine zipper gene resembling the FOS/JUN oncogenes that is highly expressed in lymphoblastoid tumors. Proceedings of the National Academy of Sciences of the United States of America. 89: 4042-4046.

  12. Kamaldeep, Sharma, P.C., Jindal, N., Narang, G. (2007). Occurrence  of Marek’s Disease in Vaccinated Poultry Flocks of Haryana (India). International Journal of Poultry Science. 6: 372-377.

  13. Krol, K., Baigent, S., Nair, V., Kozdrun, W., Samorek-Salamonowicz. (2007). Comparison of standard polymerase chain reaction (PCR) with real-time PCR for meq gene of Marek’s disease virus. Bulletin-Veterinary Institute in Pulawy. 51(1): 3-7.

  14. Lee, S.I., Takagi, M., Ohashi, K. (2000). Difference in the MEQ gene between oncogenic and attenuated strains of Marek’s disease virus serotype 1. Journal of Veterinary Medical Science. 62: 287-292.

  15. Lupiani, B., Lee, L.F., Cui, X., Gimeno, I. anderson, A., Morgan, R.W., Silva, R.F., Witter, R.L., Kung, H.J.  Reddy, S.M. (2004). Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable  for replication. Proceedings of the National Academy of Sciences. 101(32): 11815-11820.

  16. Mete, A., Gharpure, R., Pitesky, M. E., Famini, D., Sverlow, K., Dunn, J. (2016). Marek’s Disease in backyard chickens, A study of pathologic findings and viral loads in tumorous and non tumorous birds. Avian Diseases. 60: 826-836.

  17. Muniyellappa, H.K., Satyanarayana, M.L., Isloor, S., Gowda, N.S. (2015). Marek’s disease outbreak among vaccinated commercial layer flocks in the mining area of Karnataka, India. Veterinary Record. 172(17): 452-452.

  18. Murata, S., Chang, K.S., Lee, S., Konnai, S., Onuma, M., Ohashi, K. (2007). Development of a nested polymerase chain reaction method to detect oncogenic Marek’s disease virus from feather tips. Journal of Veterinary Diagnostic  Investigation. 19: 471-478.

  19. Payne, L.N., Frazier J.A., Powell, P.C. (1976). Pathogenesis of Marek’s disease. International Review Experimental Biology. 16: 59-154. 

  20. Payne, L.N., Venugopal, K. (2000). Neoplastic diseases: Marek’s disease, avian leukosis and reticuloendotheliosis. Revue Scientifique et Technique-Office International des Epizooties. 19(2): 544-560.

  21. Pejovic, N., Velhner, M., Polacek, V., Aleksic-Kovacevic S., Marinkovic, D., Knezevi M. (2007). Morphological and immunohistochemical  examination of tumor cells in Marek’s disease. Acta Veterinaria (Beograd). 57(1): 27-35.

  22. Raja, A., Dhinakar, R.G., Bhuvaneswari, P., Balachandran, C., Kumanan, K. (2009). Detection of virulent Marek’s disease virus in poultry in India. Acta Virologica. 53(4): 255-60.  doi: 0.4149/av_2009_04_255.

  23. Ramos-Vara, J.A., Webster, J.D., DuSold, D., Miller, M.A. (2014). Immunohistochemical evaluation of the effects of paraffin section storage on biomarker stability. Veterinary Pathology.  51(1): 102-109.

  24. Sani, N.A., Aliyu, H.B., Musa, I.W., Wakawa, A.M., Abalaka, S.E., Oladele, S.B., Abdu, P.A. (2017). A nine-year retrospective  study of avian neoplastic diseases in Zaria, Kaduna state, Nigeria. Sokoto Journal of Veterinary Sciences. 15(1): 36-41.

  25. Schat, A.K., Nair, V. (2008). Marek’s Disease. In: Diseases of Poultry, Saif, [Y.M., A.M. Fadly, Glisson J.R., McDougald L.R., Nolan L.K. and Swayne D.E. (Eds.)]. 12th edn., Blackwell Publishing, Iowa. 452-512.

  26. Witter, R.L., Schat, K.A. (2003). Marek’s Disease. In: [Saif, Y.M., Barnes, H.J., Glisson, J.R., Fadly, A.M., McDougald, L.R., Swayne, D.E. (Eds.)], Diseases of Poultry, 11th ed. Iowa State University Press, Ames. pp. 407465.

  27. Yunis, R., Jarosinski, K.W., Schat, K.A. (2004). Association between rate of viral genome replication and virulence of Marek’s disease herpesvirus strains. Virology. 328(1): 142-150.

  28. Zavala, G., Cheng, S. (2006). Detection and characterization of avian leukosis virus in Marek’s disease vaccines. Avian Diseases. 50(2): 209-215.

Editorial Board

View all (0)